[1]Sneyd.JR,.Rigby-Jones.AE..Remimazolam.for.anaesthesia.or.sedation..Curr.Opin.Anaesthesiol..2020.Aug;33(4):506-511.doi:10.1097/ACO.0000000000000877.PMID: 32530890.[2][22]Kim KM.Remimazolam: pharmacological characteristics and clinical applications in anesthesiology.Anesth Pain Med (Seoul).2022Jan;17(1):1-11.doi:10.17085/apm.21115. Epub 2022 Jan 20.PMID:35139608;PMCID:PMC8841266.[3][5]窦豆,栗亚茹,王璐等.新型镇静药物瑞马唑仑的研究进展[J].中国医药,2023,18(03):453-457.[4]李彦峰,王钝.瑞马唑仑[J].中国药物化学杂志,2021,31(07):572.DOI:10.14142/j.cnki.cn21-1313/r.2021.07.013.[6][7]Lee A,Shirley M.Remimazolam:A Review in Procedural Sedation.Drugs.2021 Jul;81(10):1193-1201.doi:10.1007/s40265-021-01544-8.Epub 2021 Jul 1.PMID:34196946.[8]Pantos MM,Kennedy DR,Nemec EC.Remimazolam:A Novel Option for Procedural Sedation in High Risk Patients.J Pharm Pract.2023 Feb;36(1):149-154. doi:10.1177/08971900211027303.Epub 2021 Jun 22.PMID:34155946.[9]Zhu X,Wang H,Yuan S,Li Y,Jia Y,Zhang Z,Yan F,Wang Z.Efficacy and Safety of Remimazolam in Endoscopic Sedation-A Systematic Review and Meta-Analysis.Front Med (Lausanne).2021 Jul 26;8:655042.doi:10.3389/fmed.2021.655042.PMID:34381792;PMCID:PMC8350069.[10]田有利,金明根.新药瑞马唑仑未来的潜力[J].中国处方药,2022,20(07):163-166.[11]Doi M,Morita K,Takeda J,Sakamoto A,Yamakage M,Suzuki T.Efficacy and safety of remimazolam versus propofol for general anesthesia:a multicenter,single-blind, randomized,parallel-group,phase IIb/III trial.J Anesth.2020 Aug;34(4):543-553.doi:10.1007/s00540-020-02788-6.Epub 2020 May 16.PMID:32417976.[12]Choi JY, Lee HS, Kim JY, Han DW, Yang JY, Kim MJ, Song Y. Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: A randomized non-inferiority trial.J Clin Anesth. 2022 Nov;82:110955. doi: 10.1016/j.jclinane.2022.110955. Epub 2022 Aug 25. PMID: 36029704.[13]王泽鹏,史创国,段磊等.苯磺酸瑞马唑仑用于妇科腔镜手术的效果观察[J].中国现代医药杂志,2023,25(01):60-63.[14]Dai G,Pei L,Duan F,Liao M,Zhang Y,Zhu M,Zhao Z,Zhang X.Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia.Minerva Anestesiol.2021 Oct;87(10):1073-1079.doi:10.23736/S0375-9393.21.15517-8.Epub 2021 Jul 14.PMID:34263581.[15]赵宇晗,王婷婷,胡静等.新型镇静药物瑞马唑仑的临床研究进展[J].中国新药杂志,2022,31(20):2006-2010.[16]叶冲冲,谢永鹏,骆继业等.不同剂量瑞马唑仑在ICU机械通气患者中的镇静效果及对血流动力学的影响[J].中国医药导报,2021,18(22):121-124.[17]侯成,卢光照,李文清等.氟马西尼的药理、药效和剂型应用进展[J].药学实践杂志,2017,35(06):485-489.[18]Stöhr T,Colin PJ,Ossig J，Pesic M,Borkett K,Winkle P,Struys MMRF,Schippers F.Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment.Br J Anaesth.2021 Sep;127(3):415-423.doi:10.1016/j.bja.2021.05.027.Epub 2021 Jul 8.PMID:34246461.[19]Useinovic N,Jevtovic-Todorovic V.Novel anesthetics inpediatric practice:is it time?Curr Opin Anaesthesiol.2022 Aug 1;35(4):425-435.doi:10.1097/ACO.0000000000001156.Epub 2022 Jul 5.PMID:35787582; PMCID:PMC10104442.[20]旷光华,徐伟,夏瑞.瑞马唑仑的应用现状及其研究进展[J].实用医学杂志,2022,38(13):1695-1700.[21]Wesolowski AM,Zaccagnino MP,Malapero RJ,Kaye AD,Urman RD.Remimazolam:Pharmacologic.Considerations.and.Clinical.Role.in.Anesthesiology.Pharmacotherapy.2016 Sep;36(9):1021-7.doi:10.1002/phar.1806.Epub 2016 Sep 1.PMID:27496519.
